EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LINC01116 affects patient survival differently and is dissimilarly expressed in ER + and ER − breast cancer samples

Mohammadjavad Karimi Taheri iD, Sogol Ghanbari, Akram Gholipour, Taraneh Givi, Majid Sadeghizadeh iD

Cancer Reports · 2023-08 · 6 (8)

DOI: 10.1002/cnr2.1848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, online erschienen am 15.06.2023. Verfasst von Mohammadjavad Karimi Taheri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Genetics Department, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is the most commonly detected cancer and one of the leading causes of cancer mortality. Emerging evidence supports that aberrant expression of lncRNAs is correlated with tumor progression and various aspects of tumor development.

Aim

This study aimed to evaluate the expression pattern of LINC01116 in breast cancer tissues and investigate the impact of LINC01116 on patients' survival. Methods and Results Microarray and qRT‐PCR data analysis were performed, and the KM‐plotter database was used in this study. In addition, the gain of function approach was performed to examine the effect of LINC01116 on breast cancer cells in‐vitro. The results exhibited that LINC01116 is meaningfully upregulated in the ER+ tumor specimens compared to the ER– ones. Also, relative to normal tissues, the expression of LINC01116 in ER+ and ER– tumor tissues significantly increased and decreased, respectively. ROC curve analysis revealed the power of LINC01116 in distinguishing ER+ from ER– samples. Additionally, the Kaplan‐Meier survival analysis showed that the LINC01116 expression positively correlates with survival probability in all as well as ER+ patients. However, this correlation was negative in ER– patients. Furthermore, our results showed that the overexpression of LINC01116 induces TGF‐β signaling in ER– cells (MDA‐MB‐231), and microarray data analysis revealed that LINC01116 is significantly upregulated in 17β‐Estradiol treated MCF7 cells.

Conclusion

In conclusion, our results suggest that LINC01116 can be a potential biomarker in distinguishing ER+ and ER– tissues and has different effects on patients' survival based on ER status by affecting TGF‐β and ER signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansMCF-7 CellsSignal TransductionRNA, Untranslated

Stichwörter der Autor:innen

LINC01116TGF-βbreast cancerestrogen receptorlncRNA

Substanzen

RNA, Untranslated

Autor:innen und Institutionen

  • Molecular Genetics Department, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran.
  • Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Mohammadjavad Karimi Taheri, Majid Sadeghizadeh

Zitieren

APA

Karimi Taheri, M., Ghanbari, S., Gholipour, A., Givi, T., & Sadeghizadeh, M. (2023). LINC01116 affects patient survival differently and is dissimilarly expressed in ER + and ER − breast cancer samples. Cancer Reports, 6(8). https://doi.org/10.1002/cnr2.1848

Vancouver

Karimi Taheri M, Ghanbari S, Gholipour A, Givi T, Sadeghizadeh M. LINC01116 affects patient survival differently and is dissimilarly expressed in ER + and ER − breast cancer samples. Cancer Reports. 2023;6(8). doi:10.1002/cnr2.1848

BibTeX
@article{KarimiTaheri2023,
  author = {Karimi Taheri, Mohammadjavad and Ghanbari, Sogol and Gholipour, Akram and Givi, Taraneh and Sadeghizadeh, Majid},
  title = {LINC01116 affects patient survival differently and is dissimilarly expressed in ER + and ER − breast cancer samples},
  journal = {Cancer Reports},
  year = {2023},
  volume = {6},
  number = {8},
  doi = {10.1002/cnr2.1848}
}
Kostenlos starten →